3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
420
Precursor Cell Lymphoblastic Leukemia-Lymphoma
126
Neoplasms, Plasma Cell
74
Recurrence
70
Lymphoma
57
Leukemia
54
Neoplasms
46
Immunoglobulin Light-chain Amyloidosis
38
Burkitt Lymphoma
37
Vomiting
36
Lymphoma, Mantle-Cell
32
Lymphoma, Large B-Cell, Diffuse
31
Nausea
29
Lymphoma, Non-Hodgkin
28
Breast Neoplasms
22
Waldenstrom Macroglobulinemia
21
Lymphoma, Follicular
21
Hodgkin Disease
21
Leukemia, Lymphocytic, Chronic, B-Cell
20
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Neoplasm Metastasis
17
Prostatic Neoplasms
16
Lymphoma, Extranodal NK-T-Cell
16
Amyloidosis
16
Leukemia, Myeloid, Acute
15
Smoldering Multiple Myeloma
14
Lymphoma, B-Cell, Marginal Zone
13
Lung Neoplasms
11
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, B-Cell
10
Interventions
Educational Status
3
pembrolizumab
2
anlotinib
2
Therapeutic Touch
2
Surveys and Questionnaires
2
Standard of Care
2
Radiotherapy
2
Palliative Care
2
Methods
2
Interviews as Topic
2
Early Intervention, Educational
2
Carboplatin
2
temsirolimus
1
olaparib
1
niraparib
1
fosaprepitant
1
argatroban
1
Topotecan
1
Thrombopoietin
1
Surgical Procedures, Operative
1
Practice Guidelines as Topic
1
Palonosetron
1
Paclitaxel
1
Nivolumab
1
Ipilimumab
1
Heparin, Low-Molecular-Weight
1
Filgrastim
1
Dimenhydrinate
1
Diffusion
1
Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Genital Neoplasms, Female
×
Dexamethasone
×
Clear all
NCT01074697
2015-04-24
GAND-emesis
Odense University Hospital
Phase 3
Completed
246 enrolled